Evidence map›Paper›PMID 19321868›Full record

Trial reportThe New England journal of medicine2009

Male circumcision for the prevention of HSV-2 and HPV infections and syphilis.

Aaron A R Tobian, David Serwadda, Thomas C Quinn, Godfrey Kigozi, Patti E Gravitt, Oliver Laeyendecker, Blake Charvat, Victor Ssempijja, Melissa Riedesel, Amy E Oliver and 6 more

4 registry-linked trialsOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The New England journal of medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 240 papers, 16 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
240citing papers in PubMed, 16 pooled it
65.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00124878 phase3unknown statusnot on this map

Trial of Male Circumcision: HIV, STD and Behavioral Effects in Men, Women and the Community

TypeinterventionalSponsorWawer, Maria J., M.D.Ran2003 to 2009Enrolled5,200ConditionsHIV Infections, Sexually Transmitted Diseases, Papillomavirus Infections, Genital HerpesArmsMale circumcision
NCT00425984 phase3completednot on this map

Randomized Trial of Male Circumcision for HIV Prevention, Rakai, Uganda

TypeinterventionalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2002 to 2006Enrolled5,000ConditionsHIV Infections, Herpesvirus 2, Human, Syphilis, Genital Diseases, MaleArmsAdult male circumcision
NCT02337179 nacompletednot on this mapstarted 2011, after this paper: background citation

A Pilot Study to Introduce Male Circumcision (MC) Services to Prevent HIV Infection in Two High Prevalence Areas of the Dominican Republic (DR)

TypeinterventionalSponsorUniversity of Illinois at ChicagoRan2011 to 2017Enrolled539ConditionsCircumcision, Male, HIV, AIDSArmsVoluntary medical male circumcision
NCT03338699 nacompletednot on this mapstarted 2018, after this paper: background citation

Evaluation of the ShangRing vs. Mogen Clamp for Early Infant Male Circumcision (EIMC) in Sub-Saharan Africa

TypeinterventionalSponsorWeill Medical College of Cornell UniversityRan2018 to 2020Enrolled1,380ConditionsCircumcisionArmsShangRing, Mogen clamp
3 · Its place in the literature

Who cites it

240 citing papers in PubMed, 16 syntheses or guidelines pooled it, 517 citations in OpenAlex.

  1. Pooled it
  2. Impact of Sexual Activity on the Risk of Male Genital Tumors: A Systematic Review of the Literature.International journal of environmental research and public health · 2021
    Pooled it
  3. Sexually Transmitted Infections Treatment Guidelines, 2021.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2021
    Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Interventions for men and women with their first episode of genital herpes.The Cochrane database of systematic reviews · 2016
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Sexually transmitted diseases treatment guidelines, 2015.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2015
    Guideline
  13. Pooled it
  14. Guideline
  15. Pooled it
  16. Pooled it
  17. Trial
  18. Trial
  19. Male Circumcision Reduces Penile HPV Incidence and Persistence: A Randomized Controlled Trial in Kenya.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Trial
  20. Trial

180 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Aaron A R TobianDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
David Serwadda
Thomas C Quinn
Godfrey Kigozi
Patti E Gravitt
Oliver Laeyendecker
Blake Charvat
Victor Ssempijja
Melissa Riedesel
Amy E Oliver
Rebecca G Nowak
Lawrence H Moulton
Michael Z Chen
Steven J Reynolds
Maria J Wawer
Ronald H Gray
Johns Hopkins University · USNational Institute of Allergy and Infectious Diseases · USRakai Health Sciences Program · UGJohns Hopkins Medicine · USMakerere University · UG

Funding

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVsZIAAI001040 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REYNOLDS, STEVEN · 2009 to 2025
$23.5M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
Male Circumcision Trial for HIV Prevention, Rakai-UgandaU01AI051171 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2002 to 2006
$8.9M
Immunopathogenesis Of Chlamydia trachomatis InfectionZIAAI000358 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI QUINN, THOMAS · 2009 to 2022
$7.0M
INTERNATIONAL STUDIES ON THE ACQUIRED IMMUNODEFICIENCY SYNDROMEZ01AI000361 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI QUINN, THOMAS · 1985 to 2008
$3.1M
International Training/Research in Population and Health, UgandaD43TW001508 · FIC · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2000 to 2010
$2.1M
SPECIAL POSTDOCTORAL RESEARCH PROGRAM IN AIDST22TW000015 · FIC · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SCOTT, GWENDOLYN B. · 1988 to 1999
–
FIC NIH HHS 5D43TW001508FIC NIH HHS D43TW00015FIC NIH HHS D43 TW001508FIC NIH HHS T22 TW000015Intramural NIH HHS Z01 AI000361Intramural NIH HHS Z99 AI999999NIAID NIH HHS U01 AI051171NIAID NIH HHS U01-AI-51171
6 · The paper itself

Abstract

backgroundMale circumcision significantly reduced the incidence of human immunodeficiency virus (HIV) infection among men in three clinical trials. We assessed the efficacy of male circumcision for the prevention of herpes simplex virus type 2 (HSV-2) and human papillomavirus (HPV) infections and syphilis in HIV-negative adolescent boys and men.

methodsWe enrolled 5534 HIV-negative, uncircumcised male subjects between the ages of 15 and 49 years in two trials of male circumcision for the prevention of HIV and other sexually transmitted infections. Of these subjects, 3393 (61.3%) were HSV-2-seronegative at enrollment. Of the seronegative subjects, 1684 had been randomly assigned to undergo immediate circumcision (intervention group) and 1709 to undergo circumcision after 24 months (control group). At baseline and at 6, 12, and 24 months, we tested subjects for HSV-2 and HIV infection and syphilis, along with performing physical examinations and conducting interviews. In addition, we evaluated a subgroup of subjects for HPV infection at baseline and at 24 months.

resultsAt 24 months, the cumulative probability of HSV-2 seroconversion was 7.8% in the intervention group and 10.3% in the control group (adjusted hazard ratio in the intervention group, 0.72; 95% confidence interval [CI], 0.56 to 0.92; P=0.008). The prevalence of high-risk HPV genotypes was 18.0% in the intervention group and 27.9% in the control group (adjusted risk ratio, 0.65; 95% CI, 0.46 to 0.90; P=0.009). However, no significant difference between the two study groups was observed in the incidence of syphilis (adjusted hazard ratio, 1.10; 95% CI, 0.75 to 1.65; P=0.44).

conclusionsIn addition to decreasing the incidence of HIV infection, male circumcision significantly reduced the incidence of HSV-2 infection and the prevalence of HPV infection, findings that underscore the potential public health benefits of the procedure. (ClinicalTrials.gov numbers, NCT00425984 and NCT00124878.)

Indexed as

Circumcision, MaleHerpesvirus 2, HumanAdolescentAdultCondomsConfounding Factors, EpidemiologicGenotypeHerpes GenitalisHumansIncidenceKaplan-Meier EstimateMalePapillomaviridaePapillomavirus InfectionsPrevalenceSexual Behavior

Identifiers

PMID19321868
PMCPMC2676895
OpenAlexW2170949839

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.